Status:
UNKNOWN
Development of a Screening Tool for the Risk of Vitamin D Deficiency
Lead Sponsor:
University of Pavia
Collaborating Sponsors:
Istituti Clinici Scientifici Maugeri SpA
Conditions:
Vitamin D Deficiency
Vitamin D3 Deficiency
Eligibility:
All Genders
18+ years
Brief Summary
Since vitamin D deficiency is a condition that affects a high percentage of individuals of all ages and given the attention on the possible role of the deficiency of this vitamin in the development of...
Detailed Description
It will be administered the questionnaire which includes specific and previously identified questions useful for the purpose of the study to all patients who belong to the clinic of the Dietetics and ...
Eligibility Criteria
Inclusion
- Subjects older than or equal 18 years;
- Absence of liver pathologies;
- Absence of kidney pathologies;
- Absence of intestinal malabsorption syndromes;
- Absence of bariatric surgery;
- Absence of cancer;
- Absence of primary hyperparathyroidism;
- Absence of extensive dermatological pathologies (e.g. psoriasis, atopic dermatitis, vitiligo)
- Absence of supplementation with multivitamin supplements or vitamin D;
- Absence of chronic drug therapy with: anticonvulsants, antipsychotics, glucocorticoids, immunosuppressive corticosteroids, anti-retrovirals, slimming, hypocolestrolemicants, laxatives (prolonged use);
- acceptance and sign of informed consent.
Exclusion
- Subjects under 18 years old;
- Affected by liver pathologies;
- Affected by kidney pathologies;
- Affected by intestinal malabsorption syndromes;
- Affected by cancer;
- Affected by primary hyperparathyroidism;
- Affected by extensive dermatological pathologies (e.g. psoriasis, atopic dermatitis, vitiligo).
- Candidates and/or undergoing bariatric surgery;
- Supplementation with multivitamin or vitamin D;
- Chronic therapy with: anticonvulsants, antipsychotics, glucocorticoids, immunosuppressive corticosteroids, anti-retrovirals, slimming, hypocolestrolemizzanti, laxatives (prolonged use).
Key Trial Info
Start Date :
January 14 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 31 2022
Estimated Enrollment :
190 Patients enrolled
Trial Details
Trial ID
NCT04404842
Start Date
January 14 2020
End Date
January 31 2022
Last Update
May 28 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istituti Clinici Scientifici Maugeri SpA
Pavia, Lombardy, Italy, 27100